Suppr超能文献

法国北部进行性核上性麻痹的地理聚集区。

A geographical cluster of progressive supranuclear palsy in northern France.

作者信息

Caparros-Lefebvre Dominique, Golbe Lawrence I, Deramecourt Vincent, Maurage Claude-Alain, Huin Vincent, Buée-Scherrer Valerie, Obriot Helene, Sablonnière Bernard, Caparros Francois, Buée Luc, Lees Andrew J

机构信息

From the Unit of Neurology (D.C.-L.), Centre Hospitalier de Wattrelos, France; Department of Neurology (L.I.G.), Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; University of Lille Nord de France (V.D., C.-A.M., V.H., V.B.-S., H.O., B.S., F.C., L.B.), INSERM UMR 1172, Batiment JPARC, France; and Reta Lila Weston Institute for Neurological Studies (A.J.L.), London, UK.

出版信息

Neurology. 2015 Oct 13;85(15):1293-300. doi: 10.1212/WNL.0000000000001997. Epub 2015 Sep 9.

Abstract

OBJECTIVE

To describe a cluster of progressive supranuclear palsy (PSP) in northern France. PSP has not been reported in geographical, temporal, or occupational clusters. A unit of Neurology and Neurogeriatrics opened in 2005 at the Centre Hospitalier de Wattrelos, serving the population of Wattrelos and Leers (combined population 51,551) and parts of neighboring towns. For most of the 20th century, this area was a center for chromate and phosphate ore processing, textile dyeing, and tanning. Significant industrial waste persists close to residential areas.

METHODS

From 2005 to 2014, 92 patients with PSP at Centre Hospitalier de Wattrelos were identified and studied. Detailed residential data were available in the medical records. Eighty cases have had magnetic resonance head scanning and 60 have died, of whom 13 have been examined neuropathologically.

RESULTS

The ratio of observed to expected PSP incidence over the period 2005 to 2012 was 12.3 (95% confidence interval: 7.4-35.9). Mean onset age was 74.3 years. The Richardson syndrome/PSP-parkinsonism ratio was 43%/42%. Four other phenotypes each occurred in 2% to 5%. Onset was gait/balance difficulty in 52%. None of the 92 affected patients were relatives and 7 were of North African ancestry. MRI was compatible with a clinical diagnostic of PSP in all cases. Histopathologic examination confirmed neurofibrillary degeneration and tufted astrocytes in all autopsied cases. Western blots revealed a typical tau 4R doublet. The tau H1 haplotype occurred in 95.8% of cases' chromosomes.

CONCLUSIONS

We have identified a cluster of PSP in a geographical area with severe environmental contamination by industrial metals.

摘要

目的

描述法国北部的一组进行性核上性麻痹(PSP)病例。此前未见PSP在地理、时间或职业群体中聚集发病的报道。瓦特勒洛斯中心医院于2005年开设了神经内科和神经老年病科,服务于瓦特勒洛斯和勒尔的居民(总人口51,551)以及邻近城镇的部分地区。在20世纪的大部分时间里,该地区是铬酸盐和磷酸盐矿石加工、纺织品染色及制革的中心。大量工业废料仍留存于居民区附近。

方法

2005年至2014年期间,在瓦特勒洛斯中心医院确诊并研究了92例PSP患者。病历中有详细的居住数据。80例患者进行了头部磁共振扫描,60例患者死亡,其中13例进行了神经病理学检查。

结果

2005年至2012年期间观察到的PSP发病率与预期发病率之比为12.3(95%置信区间:7.4 - 35.9)。平均发病年龄为74.3岁。理查森综合征/PSP帕金森综合征的比例为43%/42%。其他四种表型各占2%至5%。52%的患者起病表现为步态/平衡困难。92例受累患者均无亲属关系,7例为北非血统。所有病例的MRI结果均与PSP的临床诊断相符。组织病理学检查在所有尸检病例中均证实有神经原纤维变性和簇状星形胶质细胞。蛋白质免疫印迹显示典型的tau 4R双峰。tau H1单倍型出现在95.8%的病例染色体中。

结论

我们在一个受到工业金属严重环境污染的地理区域发现了一组PSP病例。

相似文献

1
A geographical cluster of progressive supranuclear palsy in northern France.
Neurology. 2015 Oct 13;85(15):1293-300. doi: 10.1212/WNL.0000000000001997. Epub 2015 Sep 9.
2
Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.
JAMA Neurol. 2019 Jun 1;76(6):710-717. doi: 10.1001/jamaneurol.2019.0250.
3
5
Familial aggregation of parkinsonism in progressive supranuclear palsy.
Neurology. 2009 Jul 14;73(2):98-105. doi: 10.1212/WNL.0b013e3181a92bcc. Epub 2009 May 20.
6
Further extension of the H1 haplotype associated with progressive supranuclear palsy.
Mov Disord. 2002 May;17(3):550-6. doi: 10.1002/mds.10076.
8
Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
Neurodegener Dis. 2008;5(6):339-46. doi: 10.1159/000121388. Epub 2008 Mar 18.
9
Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Mov Disord. 2005 Aug;20 Suppl 12:S21-8. doi: 10.1002/mds.20536.

引用本文的文献

1
Comorbid pathologies and their impact on progressive supranuclear palsy: current view.
J Neural Transm (Vienna). 2025 Aug 12. doi: 10.1007/s00702-025-03005-y.
4
Endemic parkinsonism: clusters, biology and clinical features.
Nat Rev Neurol. 2023 Oct;19(10):599-616. doi: 10.1038/s41582-023-00866-3. Epub 2023 Sep 8.
5
Genetic and Epigenetic Constructs of Progressive Supranuclear Palsy.
Ann Neurosci. 2022 Apr;29(2-3):177-188. doi: 10.1177/09727531221089396. Epub 2022 Apr 27.
6
Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies.
Nat Rev Neurol. 2021 Oct;17(10):601-620. doi: 10.1038/s41582-021-00541-5. Epub 2021 Aug 23.
7
Cellular and pathological heterogeneity of primary tauopathies.
Mol Neurodegener. 2021 Aug 23;16(1):57. doi: 10.1186/s13024-021-00476-x.
8
Environmental Risk Factors for Progressive Supranuclear Palsy.
J Mov Disord. 2021 May;14(2):103-113. doi: 10.14802/jmd.20173. Epub 2021 May 26.
9
Gene-Environment Interactions in Progressive Supranuclear Palsy.
Front Neurol. 2021 Apr 9;12:664796. doi: 10.3389/fneur.2021.664796. eCollection 2021.
10
Progressive Supranuclear Palsy and Corticobasal Degeneration.
Adv Exp Med Biol. 2021;1281:151-176. doi: 10.1007/978-3-030-51140-1_11.

本文引用的文献

1
Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam.
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1144-9. doi: 10.1073/pnas.1322614111. Epub 2014 Jan 6.
2
Similarities between familial and sporadic autopsy-proven progressive supranuclear palsy.
Neurology. 2013 May 28;80(22):2076-8. doi: 10.1212/WNL.0b013e318294b2eb. Epub 2013 May 1.
4
Risk factors for progressive supranuclear palsy: a case-control study in France.
J Neurol Neurosurg Psychiatry. 2009 Nov;80(11):1271-4. doi: 10.1136/jnnp.2008.149849.
5
Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies.
Exp Neurol. 2009 Nov;220(1):133-42. doi: 10.1016/j.expneurol.2009.08.004. Epub 2009 Aug 13.
7
The epidemiology of progressive supranuclear palsy.
Handb Clin Neurol. 2008;89:457-9. doi: 10.1016/S0072-9752(07)01242-0.
8
Arsenic, cadmium and lead in medicinal herbs and their fractionation.
Food Chem Toxicol. 2008 Aug;46(8):2871-5. doi: 10.1016/j.fct.2008.05.027. Epub 2008 Jun 3.
9
A clinical rating scale for progressive supranuclear palsy.
Brain. 2007 Jun;130(Pt 6):1552-65. doi: 10.1093/brain/awm032. Epub 2007 Apr 2.
10
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.
Neurobiol Dis. 2007 Mar;25(3):561-70. doi: 10.1016/j.nbd.2006.10.018. Epub 2006 Dec 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验